Quince Therapeutics (QNCX) Operating Expenses (2018 - 2026)
Quince Therapeutics (QNCX) posted quarterly Operating Expenses of $14.6 million for Q1 2026, down 1.8% year-over-year from $14.9 million in Q1 2025, and down 24.61% quarter-over-quarter from $19.4 million in Q4 2025.
Quince Therapeutics (QNCX) Operating Expenses (2018 - 2026) Analysis & Trends
Quince Therapeutics' Operating Expenses history runs 9 years deep, the most recent figure standing at $14.6 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 1.8% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $57.8 million (down 5.13% YoY), while the FY2025 annual figure was $58.1 million, up 1.37% from the prior year.
- Operating Expenses for Q1 2026 stood at $14.6 million, down from $19.4 million in the prior quarter.
- The five-year high for Operating Expenses was $28.2 million in Q2 2024, with the low at $5.6 million in Q2 2023.
- The 5-year median for Operating Expenses is $12.5 million (2023), against an average of $13.1 million.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses tumbled 64.85% in 2022, then surged 404.87% in 2024.
- Quince Therapeutics' Operating Expenses stood at $16.2 million in 2022, then sank by 38.81% to $9.9 million in 2023, then grew by 21.08% to $12.0 million in 2024, then surged by 61.11% to $19.4 million in 2025, then declined by 24.61% to $14.6 million in 2026.
- Business Quant data shows QNCX's Operating Expenses at $14.6 million in Q1 2026, $19.4 million in Q4 2025, and $13.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 541.02 Mn |
| 10 | Quince Therapeutics | 200.91 Mn | 200.91 Mn | - | 79.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.59 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Sep 30, 2025 | 13.43 Mn |
| Jun 30, 2025 | 10.43 Mn |
| Mar 31, 2025 | 14.86 Mn |
| Dec 31, 2024 | 12.01 Mn |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 28.19 Mn |
| Mar 31, 2024 | 11.22 Mn |
| Dec 31, 2023 | 9.92 Mn |
| Sep 30, 2023 | 6.09 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Mar 31, 2023 | 12.96 Mn |
| Dec 31, 2022 | 16.21 Mn |
| Sep 30, 2022 | 7.62 Mn |
| Mar 31, 2022 | 21.86 Mn |
| Dec 31, 2021 | 23.54 Mn |
| Sep 30, 2021 | 21.68 Mn |
| Jun 30, 2021 | 21.78 Mn |
| Mar 31, 2021 | 23.31 Mn |